Una aproximación a la tuberculosis resistente a isoniazida: ¿un problema subestimado en Colombia?

Objective: To describe the clinical characteristics and outcomes to the treatment of patients with isoniazid-resistant tuberculosis (Hr-TB) in an institution in southwest Colombia. Materials and methods: A retrospective observational study was conducted. Patients with diagnostic confirmation, micr...

Full description

Bibliographic Details
Main Author: José Fernando García-Goez
Format: Article
Language:English
Published: Asociación Colombiana de Infectología 2020-04-01
Series:Infectio
Subjects:
Online Access:https://www.revistainfectio.org/index.php/infectio/article/view/863
id doaj-7cc5608b9152445ab9a7923d6fbf020a
record_format Article
spelling doaj-7cc5608b9152445ab9a7923d6fbf020a2020-11-25T03:58:23ZengAsociación Colombiana de InfectologíaInfectio0123-93922020-04-0124317318110.22354/in.v24i3.863Una aproximación a la tuberculosis resistente a isoniazida: ¿un problema subestimado en Colombia?José Fernando García-Goez0 Fundación Valle del Lili, Departamento de Medicina Interna, Servicio de Enfermedades Infecciosas; Universidad Icesi, Facultad de Ciencias de la SaludObjective: To describe the clinical characteristics and outcomes to the treatment of patients with isoniazid-resistant tuberculosis (Hr-TB) in an institution in southwest Colombia. Materials and methods: A retrospective observational study was conducted. Patients with diagnostic confirmation, microbiological isolation, drug susceptibility tests, and evidence of Hr-TB were included. Results: Thirty-two patients with Hr-TB were included between 2006-2018, corresponding to 6% (32/528) of resistance in total cases. 78% were new cases, primary resistance, and 22% previously treated, acquired resistance. The most frequent comorbidity was HIV infection (n = 9). The pattern of Hr-TB showed in 23 (72%) cases with high level, 4 (12%) of low level and 5 (16%) with low and high level. The analysis of treatment results was performed on 22 patients, presenting 50% cure, 41% completed treatment, and 9% death related to tuberculosis. Conclusions: Hr-TB predominates in new cases, which is an obstacle to treatment where susceptibility tests are not performed routinely. https://www.revistainfectio.org/index.php/infectio/article/view/863mycobacterium tuberculosistuberculosisisoniazidmicrobial drug resistance
collection DOAJ
language English
format Article
sources DOAJ
author José Fernando García-Goez
spellingShingle José Fernando García-Goez
Una aproximación a la tuberculosis resistente a isoniazida: ¿un problema subestimado en Colombia?
Infectio
mycobacterium tuberculosis
tuberculosis
isoniazid
microbial drug resistance
author_facet José Fernando García-Goez
author_sort José Fernando García-Goez
title Una aproximación a la tuberculosis resistente a isoniazida: ¿un problema subestimado en Colombia?
title_short Una aproximación a la tuberculosis resistente a isoniazida: ¿un problema subestimado en Colombia?
title_full Una aproximación a la tuberculosis resistente a isoniazida: ¿un problema subestimado en Colombia?
title_fullStr Una aproximación a la tuberculosis resistente a isoniazida: ¿un problema subestimado en Colombia?
title_full_unstemmed Una aproximación a la tuberculosis resistente a isoniazida: ¿un problema subestimado en Colombia?
title_sort una aproximación a la tuberculosis resistente a isoniazida: ¿un problema subestimado en colombia?
publisher Asociación Colombiana de Infectología
series Infectio
issn 0123-9392
publishDate 2020-04-01
description Objective: To describe the clinical characteristics and outcomes to the treatment of patients with isoniazid-resistant tuberculosis (Hr-TB) in an institution in southwest Colombia. Materials and methods: A retrospective observational study was conducted. Patients with diagnostic confirmation, microbiological isolation, drug susceptibility tests, and evidence of Hr-TB were included. Results: Thirty-two patients with Hr-TB were included between 2006-2018, corresponding to 6% (32/528) of resistance in total cases. 78% were new cases, primary resistance, and 22% previously treated, acquired resistance. The most frequent comorbidity was HIV infection (n = 9). The pattern of Hr-TB showed in 23 (72%) cases with high level, 4 (12%) of low level and 5 (16%) with low and high level. The analysis of treatment results was performed on 22 patients, presenting 50% cure, 41% completed treatment, and 9% death related to tuberculosis. Conclusions: Hr-TB predominates in new cases, which is an obstacle to treatment where susceptibility tests are not performed routinely.
topic mycobacterium tuberculosis
tuberculosis
isoniazid
microbial drug resistance
url https://www.revistainfectio.org/index.php/infectio/article/view/863
work_keys_str_mv AT josefernandogarciagoez unaaproximacionalatuberculosisresistenteaisoniazidaunproblemasubestimadoencolombia
_version_ 1724457498188972032